Objective: To investigate the correlation and clinical significance between the serum Fractalkine (FKN) and interleukin-6 (IL-6), C-reactive protein (CRP), BNP, CK, CK-MB, TC, TG, LDL-C, HDL-C levels in patients with ...Objective: To investigate the correlation and clinical significance between the serum Fractalkine (FKN) and interleukin-6 (IL-6), C-reactive protein (CRP), BNP, CK, CK-MB, TC, TG, LDL-C, HDL-C levels in patients with coronary atherosclerotic heart disease (CHD). Methods: A total of 95 cases of patients with coronary heart disease were admitted to the Department of Cardiology, the First Affiliated Hospital of Xinjiang Medical University, March 2016 to December 2016, including 52 patients with stable angina pectoris (SAP) and 43 patients with Acute coronary syndrome (ACS), 45 matched healthy subjects were collected. The Serum levels of FKN were detected by ELISA. The correlation and significance of FKN and clinical indexes were analyzed. Results: (1) the levels of serum FKN, IL-6, CRP, BNP, CK, CK-MB, TC, TG, LDL-C in the SAP group and ACS group were significantly higher than those in the control group, HDL-C were significantly decreased. Compared with SAP group, serum FKN level was significantly increased and IL-6, CRP, BNP, CK and CK-MB levels were significantly increased in ACS group, TC, TG, LDL-C, HDL-C levels were not significant difference between SAP group and ACS group. (2) Correlation analyses showed that there was a significant positive correlation between FKN levels and IL-6, CRP, BNP, CK, CK-MB, LDL-C, significant Negative correlation between FKN levels and HDL-C, weakly positive correlation between FKN levels and TC, and no correlation between FKN levels and TG. Conclusions: The serum levels of FKN in patients with CHD are significantly increased, which are closely related to the inflammatory reaction and can be used as biomarker of CHD for early diagnosis and prognosis.展开更多
基金the National Natural Science Foundation of China.
文摘Objective: To investigate the correlation and clinical significance between the serum Fractalkine (FKN) and interleukin-6 (IL-6), C-reactive protein (CRP), BNP, CK, CK-MB, TC, TG, LDL-C, HDL-C levels in patients with coronary atherosclerotic heart disease (CHD). Methods: A total of 95 cases of patients with coronary heart disease were admitted to the Department of Cardiology, the First Affiliated Hospital of Xinjiang Medical University, March 2016 to December 2016, including 52 patients with stable angina pectoris (SAP) and 43 patients with Acute coronary syndrome (ACS), 45 matched healthy subjects were collected. The Serum levels of FKN were detected by ELISA. The correlation and significance of FKN and clinical indexes were analyzed. Results: (1) the levels of serum FKN, IL-6, CRP, BNP, CK, CK-MB, TC, TG, LDL-C in the SAP group and ACS group were significantly higher than those in the control group, HDL-C were significantly decreased. Compared with SAP group, serum FKN level was significantly increased and IL-6, CRP, BNP, CK and CK-MB levels were significantly increased in ACS group, TC, TG, LDL-C, HDL-C levels were not significant difference between SAP group and ACS group. (2) Correlation analyses showed that there was a significant positive correlation between FKN levels and IL-6, CRP, BNP, CK, CK-MB, LDL-C, significant Negative correlation between FKN levels and HDL-C, weakly positive correlation between FKN levels and TC, and no correlation between FKN levels and TG. Conclusions: The serum levels of FKN in patients with CHD are significantly increased, which are closely related to the inflammatory reaction and can be used as biomarker of CHD for early diagnosis and prognosis.
